Pharma Focus Asia

Huaren Pharmaceutical to invest 10.2 mln yuan to set up medical technology JV in Jinan

Monday, August 14, 2017

Huaren Pharmaceutical Co Ltd Says co plans to invest 10.2 million yuan to set up a Jinan-based medical technology joint venture with Shandong Novatech Information System Co. Ltd (partner).

Says the joint venture will be mainly engaged in R&D, production, promotion and sales of medical treatment combination products of nephropathy.

Says co and partner will hold a 51 percent stake and a 49 percent stake in the joint venture.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024